ClinConnect ClinConnect Logo
Search / Trial NCT06399250

Three Channel Food Concept: the Effect Meal Service on Food Intake During Hospitalization

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Apr 30, 2024

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a new meal service in the hospital affects the amount of food patients eat. The study aims to understand if this "three channel food concept" can help improve the energy and protein intake of patients who may not be getting enough nutrition while they are hospitalized. Researchers will measure how much food is eaten by weighing the leftovers on patients' plates after meals.

To participate in this study, you need to be at least 18 years old and admitted to a surgical ward at MUMC+ for at least three days. However, if you are receiving nutrition through a tube or are not allowed to eat anything, you won’t be eligible. If you join the study, you can expect that your food intake will be monitored as part of your regular care, and your thoughts about the meals will also be considered. This study is important because it aims to improve the nutrition of patients during their hospital stay, which can help with recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • \>18y
  • Admitted to surgical nursing wards of MUMC+
  • Expected hospital stay of at least 3 days
  • Exclusion Criteria:
  • Receiving (par)enteral nutrition
  • "NPO" (nil per os) policy

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Maastricht, , Netherlands

Patients applied

0 patients applied

Trial Officials

Luc JC van Loon, PhD

Principal Investigator

Maastricht University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported